PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27800629-1	2017	WHAT IS KNOWN AND OBJECTIVE: Polymorphisms in cytochrome P450 2D6 and 2C19 can lead to interindividual differences in drug plasma concentrations, affecting clomipramine efficacy.	Clomipramine	156-168	cytochrome P450 2D6	Homo sapiens	46-74	
9579300-6	1998	Since the patient was genotypically and phenotypically a cytochrome P450 2D6 poor metabolizer, the authors attribute the relevant pharmacokinetic interaction to another clomipramine-metabolizing enzyme.	Clomipramine	169-181	cytochrome P450 2D6	Homo sapiens	57-76